the 3rd edition of LEUKEMIA 360 , a major event taking place on November 17, 2026, in Paris, aimed at becoming the first international meeting devoted to academia-industry leukemia R&D&I partnerships . This unique forum will bring together academic experts (researchers, clinicians, and operational staff from 75 research teams), industry leaders and specialists, innovators, investors, and patient representatives, working in the field of leukemia and related diseases. The goal: to foster connections, stimulate collaborative R&D, and build strategic partnerships across the entire value chain — from the identification of novel therapeutic targets to industrial development.